Doctors have zero visibility into patient behavior, medication adherence, and symptom progression after a clinic visit, leading to poor health outcomes and repeating cycles of avoidable treatment complications.
Doctors have zero visibility into patient behavior, medication adherence, and symptom progression after a clinic visit, leading to poor health outcomes and repeating cycles of avoidable treatment complications.
please be brutal, real insights only as a user and is this problem worth to be solved
The app is easy to build. The hard part is the legality and strict guidelines you would have to have to handle patient info.
commentI agree with the other comment. The app is easy to build. The hard part is the legality and strict guidelines you would have to have to handle patient info. Not to mention, if the patient forgets to take their meds, what makes you think they will remember to keep up with the app? I can see the app as something that nearly 75% of patients (or higher) completely ignores after their visit.
what makes you think they will remember to keep up with the app? I can see the app as something that nearly 75% of patients (or higher) completely ignores after their visit.
commentI agree with the other comment. The app is easy to build. The hard part is the legality and strict guidelines you would have to have to handle patient info. Not to mention, if the patient forgets to take their meds, what makes you think they will remember to keep up with the app? I can see the app as something that nearly 75% of patients (or higher) completely ignores after their visit.
Solo and small-group practitioners trying to monitor chronic disease and post-visit recovery without drowning in admin overhead.
Multiple mentions of the post-visit blind spot, patient abandonment challenges, and stringent healthcare regulatory hurdles.
Frictionless patient reporting via web/SMS without requiring app downloads or login credentials, combined with EHR-ready clinical summaries.
A lightweight, secure post-visit asynchronous check-in workflow that captures structured patient adherence and symptom updates, auto-summarizing them into the EHR prior to follow-up.
Clinicians waste hours questioning patients from scratch and managing preventable complications; $199/mo is easily justified by saved consultation time and improved quality-of-care metrics.
“Close the gap between patient home behavior and clinical visits in 6 weeks.”
A lightweight, secure post-visit asynchronous check-in workflow that captures structured patient adherence and symptom updates, auto-summarizing them into the EHR prior to follow-up.
Target outpatient clinics and primary care networks via direct physician outreach and medical community forums (r/medicine, physician networking groups)
Patients frequently abandon tracking apps after initial visits, starving the workflow of ongoing data.
Strict regulatory requirements for handling Protected Health Information (PHI) complicate early engineering.
Doctors may resist adopting another dashboard if it is not seamlessly integrated into existing EHR systems.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
It sits at the intersection of "ai-powered", "compliance", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
